CME Group Inc. $CME Shares Bought by Capital Wealth Planning LLC

Capital Wealth Planning LLC boosted its holdings in shares of CME Group Inc. (NASDAQ:CME) by 7.0% in the 4th quarter, Holdings Channel.com reports. The fund owned 2,709,146 shares of the financial services provider’s stock after buying an additional 176,640 shares during the quarter. CME Group makes up about 4.8% of Capital Wealth Planning LLC’s holdings, making the stock its 9th biggest holding. Capital Wealth Planning LLC’s holdings in CME Group were worth $736,196,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Asset Dedication LLC increased its stake in CME Group by 64.9% during the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 37 shares during the last quarter. FNY Investment Advisers LLC acquired a new stake in CME Group during the fourth quarter worth $27,000. Hilton Head Capital Partners LLC acquired a new stake in CME Group during the fourth quarter worth $28,000. Legacy Wealth Managment LLC ID increased its stake in CME Group by 191.9% during the fourth quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock worth $29,000 after acquiring an additional 71 shares during the last quarter. Finally, Global Wealth Strategies & Associates increased its stake in CME Group by 1,250.0% during the fourth quarter. Global Wealth Strategies & Associates now owns 108 shares of the financial services provider’s stock worth $30,000 after acquiring an additional 100 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Activity at CME Group

In related news, General Counsel Jonathan L. Marcus sold 3,291 shares of CME Group stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $333.37, for a total value of $1,097,120.67. Following the completion of the transaction, the general counsel directly owned 7,192 shares in the company, valued at approximately $2,397,597.04. This trade represents a 31.39% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Terrence A. Duffy sold 35,000 shares of CME Group stock in a transaction on Friday, May 15th. The shares were sold at an average price of $298.51, for a total value of $10,447,850.00. Following the completion of the transaction, the chief executive officer owned 55,630 shares of the company’s stock, valued at approximately $16,606,111.30. This trade represents a 38.62% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 44,044 shares of company stock worth $13,297,507. Company insiders own 0.30% of the company’s stock.

CME Group Trading Up 3.1%

NASDAQ:CME opened at $263.80 on Thursday. The firm has a market cap of $95.59 billion, a PE ratio of 22.51, a price-to-earnings-growth ratio of 2.86 and a beta of 0.21. The stock has a fifty day moving average price of $286.00 and a 200 day moving average price of $288.28. CME Group Inc. has a 12-month low of $244.56 and a 12-month high of $329.16. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.11 by $0.25. The firm had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.CME Group’s revenue was up 14.5% compared to the same quarter last year. During the same period last year, the business posted $2.80 earnings per share. Sell-side analysts anticipate that CME Group Inc. will post 12.28 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be issued a $1.30 dividend. The ex-dividend date is Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a yield of 2.0%. CME Group’s dividend payout ratio (DPR) is 44.37%.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on CME shares. Rothschild & Co Redburn cut their target price on CME Group from $340.00 to $316.00 and set a “neutral” rating for the company in a research note on Monday, April 27th. Weiss Ratings restated a “buy (a-)” rating on shares of CME Group in a research report on Friday, May 29th. Morgan Stanley lowered their price target on CME Group from $362.00 to $353.00 and set an “overweight” rating for the company in a research report on Thursday, April 23rd. TD Cowen lowered their price target on CME Group from $340.00 to $323.00 and set a “buy” rating for the company in a research report on Thursday, April 23rd. Finally, JPMorgan Chase & Co. raised their price target on CME Group from $266.00 to $271.00 and gave the stock an “underweight” rating in a research report on Thursday, April 16th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $305.29.

CME Group News Roundup

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME Group launched Nasdaq CME Crypto Index futures, a regulated cash-settled product tied to a benchmark of major cryptocurrencies including Bitcoin, Solana, XRP and others. The new offering could attract more trading volume from investors seeking broad crypto exposure and hedging tools. Article Title
• Positive Sentiment: CME Group and Morningstar announced an exclusive multi-year licensing agreement to launch derivatives based on Morningstar equity index benchmarks, opening a new product line tied to indexes that underpin more than $3 trillion in linked assets. Article Title
• Positive Sentiment: Shareholders maintained CME’s Class B governance structure and rejected a bid to end those director election rights, removing a potential governance overhang and preserving the company’s current control framework. Article Title
• Neutral Sentiment: CME also announced its second-quarter 2026 earnings release date for July 22, which is mainly a scheduling update but keeps attention on upcoming results. Article Title
• Neutral Sentiment: Reports about short interest and options activity suggest traders are watching CME closely, but those items do not yet point to a clear fundamental catalyst. Article Title

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.